Rafoxanide and closantel inhibit SPAK and OSR1 kinases by binding to a highly conserved allosteric site on their C-terminal domains

Mubarak A. AlAmri, Hachemi Kadri, Luke J. Alderwick, Nigel S. Simpkins, Youcef Mehellou

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)639-645
    JournalChemMedChem
    Volume12
    Issue number9
    Early online date31 Mar 2017
    DOIs
    Publication statusPublished - 9 May 2017

    Bibliographical note

    Note: This work was supported by the Medical Research Council [reference: MC_PC_14107].

    Keywords

    • Biological sciences

    Cite this